<DOC>
	<DOCNO>NCT03079206</DOCNO>
	<brief_summary>The propose study intend compare outcome food challenge hazelnut allergic patient outcome basophile activation test use hazelnut extract component .</brief_summary>
	<brief_title>Basophile Activation Testing ( BAT ) Hazelnut Allergy ( Hazelnut BAT Study )</brief_title>
	<detailed_description>Accurate diagnosis food allergy depend food challenge outcome . The propose study intend compare outcome food challenge hazelnut allergic patient outcome basophile activation test use hazelnut extract component evaluate diagnostic utility basophile activation test . With view towards improve vitro diagnostic method , investigator intend evaluate diagnostic potential basophile activation test patient hazelnut allergy confirm positive provocation support convincing history anaphylactic reaction ( ) hazelnut past , patient pollinosis symptom hazelnut allergy non-atopic control subject .</detailed_description>
	<mesh_term>Hypersensitivity</mesh_term>
	<mesh_term>Food Hypersensitivity</mesh_term>
	<criteria>Primary Inclusion criterion : Male female subject , age â‰¥ 14 year Informed Consent document signature Secondary inclusion criterion Group A : positive case history allergic reaction ( ) hazelnut positive doubleblind placebocontrolled food challenge hazelnut positive titrate open food challenge hazelnut unambiguous case history anaphylactic reaction hazelnut include without provocation Group B : positive skin test ( SPT ) birch pollen hazelnut negative food provocation hazelnut . Group C : negative case history hazelnut birch allergy negative skin test ( SPT ) hazelnut birch pollen negative food provocation hazelnut Drugs allow due interference food challenge ( short interval last treatment food challenge ) : corticosteroid systemically ( 2 week ) , antihistamine ( 3 day ) , beta blocker ( 1 day ) , angiotensin convert enzyme ( ACE ) inhibitor ( 2 day ) , omalizumab ( 2 month ) Women pregnant Lack safe contraception Uncontrolled asthma , force expiratory volume ( 1 second ) &lt; 70 % predict value Acute allergic disease Chronic urticaria Mastocytosis Other clinically significant concomitant disease state Known suspect noncompliance , drug alcohol abuse , Inability follow procedure study Participation another study investigational drug within 30 day precede present study</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>hazelnut</keyword>
	<keyword>allergen</keyword>
	<keyword>basophile-activation-test</keyword>
	<keyword>food</keyword>
	<keyword>allergy</keyword>
</DOC>